Pharmacokinetics of Riluzole in Beagle Dogs.
Journal
Drug research
ISSN: 2194-9387
Titre abrégé: Drug Res (Stuttg)
Pays: Germany
ID NLM: 101602406
Informations de publication
Date de publication:
Jan 2019
Jan 2019
Historique:
pubmed:
11
7
2018
medline:
4
4
2019
entrez:
11
7
2018
Statut:
ppublish
Résumé
Riluzole is a benzothiazole anticonvulsant used in the treatment of patients with amyotrophic lateral sclerosis and it is being investigated for clinical use in patients with spinal cord injury. The present study evaluated the pharmacokinetics of riluzole in beagle dogs after oral dose administration. The oral doses (1.5, 5, 15 and 50 mg/kg) of riluzole were administered to beagle dogs and blood samples were collected from 0 h to 24 h post drug administration. Riluzole was quantified by liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). The method was sensitive, precise, accurate and selective to riluzole quantification in plasma of beagle dogs. The pharmacokinetics following oral administration was linear from 1.5 to 15 mg/kg and the t The riluzole pharmacokinetics was linear up to 15 mg/kg and had a significantlyshorter t
Sections du résumé
BACKGROUND
BACKGROUND
Riluzole is a benzothiazole anticonvulsant used in the treatment of patients with amyotrophic lateral sclerosis and it is being investigated for clinical use in patients with spinal cord injury. The present study evaluated the pharmacokinetics of riluzole in beagle dogs after oral dose administration.
METHODS
METHODS
The oral doses (1.5, 5, 15 and 50 mg/kg) of riluzole were administered to beagle dogs and blood samples were collected from 0 h to 24 h post drug administration. Riluzole was quantified by liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS).
RESULTS
RESULTS
The method was sensitive, precise, accurate and selective to riluzole quantification in plasma of beagle dogs. The pharmacokinetics following oral administration was linear from 1.5 to 15 mg/kg and the t
CONCLUSION
CONCLUSIONS
The riluzole pharmacokinetics was linear up to 15 mg/kg and had a significantlyshorter t
Substances chimiques
Riluzole
7LJ087RS6F
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
40-45Informations de copyright
© Georg Thieme Verlag KG Stuttgart · New York.
Déclaration de conflit d'intérêts
The authors have no conflict of interests.